CO.DON AG, DE000A1K0227

CO.DON AG, DE000A1K0227

12.07.2017 - 16:13:56

CO.DON AG: EU approval of the articular cartilage product by the European Commission

CO.DON AG (ISIN: DE DE000A1K0227)

EU approval of the articular cartilage product by the European Commission

Berlin / Teltow, 12 July 2017 - Today, CO.DON AG received the Commission's implementing decision of 10.07.2017 on the granting of marketing authorization for the human pharmaceutical product "Spherox - Spheroids from human autologous matrix-associated chondrocytes", pursuant to Regulation (EC ) No 726/2004 of the European Parliament and of the Council. The approved indication is the repair of symptomatic joint cartilage defects of the ICRS grade III or IV of the femoral condylar and the patella of the knee with defects of up to 10 cm² in adults.

Further Informationen:

Matthias Meißner, M.A.

Investor Relations

ir@codon.de

12-Jul-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: CO.DON AG Warthestraße 21 14513 Teltow

Germany Phone: 03328 43460 Fax: 03328 434643 E-mail: info@codon.de Internet: www.codon.de ISIN: DE000A1K0227 WKN: A1K022 Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange   End of Announcement DGAP News Service

592189  12-Jul-2017 CET/CEST

@ dgap.de

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!